Incidence of maternal peripartum infection: A systematic review and meta-analysis. by Woodd, Susannah L et al.
LSHTM Research Online
Woodd, Susannah L; Montoya, Ana; Barreix, Maria; Pi, Li; Calvert, Clara; Rehman, An-
drea M; Chou, Doris; Campbell, Oona MR; (2019) Incidence of maternal peripartum infection:
A systematic review and meta-analysis. PLOS Medicine, 16 (12). e1002984-e1002984. DOI:
https://doi.org/10.1371/journal.pmed.1002984
Downloaded from: http://researchonline.lshtm.ac.uk/id/eprint/4655503/
DOI: https://doi.org/10.1371/journal.pmed.1002984
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
RESEARCH ARTICLE
Incidence of maternal peripartum infection: A
systematic review and meta-analysis
Susannah L. WooddID1*, Ana Montoya2, Maria BarreixID3, Li PiID4, Clara CalvertID1,
Andrea M. RehmanID1, Doris ChouID3, Oona M. R. CampbellID1
1 Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London,
United Kingdom, 2 Box Hill Hospital, Eastern Health, Victoria, Australia, 3 Department of Reproductive
Health and Research, World Health Organization, Geneva, Switzerland, 4 West China School of Public
Health, Sichuan University, Chengdu, China
* susannah.woodd@lshtm.ac.uk
Abstract
Background
Infection is an important, preventable cause of maternal morbidity, and pregnancy-related
sepsis accounts for 11% of maternal deaths. However, frequency of maternal infection is
poorly described, and, to our knowledge, it remains the one major cause of maternal mortal-
ity without a systematic review of incidence. Our objective was to estimate the average
global incidence of maternal peripartum infection.
Methods and findings
We searched Medline, EMBASE, Global Health, and five other databases from January
2005 to June 2016 (PROSPERO: CRD42017074591). Specific outcomes comprised chor-
ioamnionitis in labour, puerperal endometritis, wound infection following cesarean section or
perineal trauma, and sepsis occurring from onset of labour until 42 days postpartum. We
assessed studies irrespective of language or study design. We excluded conference
abstracts, studies of high-risk women, and data collected before 1990. Three reviewers
independently selected studies, extracted data, and appraised quality. Quality criteria for
incidence/prevalence studies were adapted from the Joanna Briggs Institute. We used ran-
dom-effects models to obtain weighted pooled estimates of incidence risk for each outcome
and metaregression to identify study-level characteristics affecting incidence. From 31,528
potentially relevant articles, we included 111 studies of infection in women in labour or post-
partum from 46 countries. Four studies were randomised controlled trials, two were before–
after intervention studies, and the remainder were observational cohort or cross-sectional
studies. The pooled incidence in high-quality studies was 3.9% (95% Confidence Interval
[CI] 1.8%–6.8%) for chorioamnionitis, 1.6% (95% CI 0.9%–2.5%) for endometritis, 1.2%
(95% CI 1.0%–1.5%) for wound infection, 0.05% (95% CI 0.03%–0.07%) for sepsis, and
1.1% (95% CI 0.3%–2.4%) for maternal peripartum infection. 19% of studies met all quality
criteria. There were few data from developing countries and marked heterogeneity in study
designs and infection definitions, limiting the interpretation of these estimates as measures
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of global infection incidence. A limitation of this review is the inclusion of studies that were
facility-based or restricted to low-risk groups of women.
Conclusions
In this study, we observed pooled infection estimates of almost 4% in labour and between
1%–2% of each infection outcome postpartum. This indicates maternal peripartum infection
is an important complication of childbirth and that preventive efforts should be increased in
light of antimicrobial resistance. Incidence risk appears lower than modelled global esti-
mates, although differences in definitions limit comparability. Better-quality research, using
standard definitions, is required to improve comparability between study settings and to
demonstrate the influence of risk factors and protective interventions.
Author summary
Why was this study done?
• Maternal infections during pregnancy and childbirth are a leading cause of preventable
death in both the mother and child.
• It is unknown how frequently maternal infections occur because existing studies have
not been summarised previously, to our knowledge.
• It is important for decision makers and clinical staff to know how common these infec-
tions are so that efforts are made to prevent them.
• One key reason it is difficult to summarise data on maternal infections is that the
research community has used a wide variety of differing criteria to classify women as
having an infection.
What did the researchers do and find?
• We screened 31,528 research articles and included 111 in a systematic review of mater-
nal peripartum infection, defined by the World Health Organization as infection of the
genital tract and surrounding tissues during labour and up to 42 days after birth. We
included articles published in all languages that would provide an estimate of the fre-
quency of infection and found data from 46 countries.
• Using meta-analysis to combine the estimates of infection and account for variability
between studies, we found that for 1,000 women giving birth, we estimated averages of
39 women with chorioamnionitis, 16 women with endometritis, 12 women with wound
infection, and 0.5 women with sepsis.
• Estimates of infection varied considerably between different studies, partly explained by
world region, the study design, and the criteria used to determine infection.
Incidence of maternal peripartum infection
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What do these findings mean?
• Infection is an important complication for many women at and after giving birth, and
infection prevention should be a priority for clinicians and policymakers. However, our
study found less infection than has been previously estimated.
• Representative data from all world regions were not available, highlighting knowledge
gaps.
• Future research will benefit from the use of standardised infection definitions and
good-quality study methods.
Introduction
Infection is an important preventable cause of maternal morbidity and mortality, with preg-
nancy-related sepsis accounting for approximately 11% (95% uncertainty interval 5.9%–
18.6%) of maternal deaths globally [1]. Infection also contributes significantly to deaths from
other causes [2] and leads to serious consequences, including chronic pelvic inflammatory dis-
ease, ectopic pregnancy, and infertility [3]. Intrapartum fever also increases the risk of perina-
tal death [4]. Improved understanding of maternal infection is key to achieving the sustainable
development goals (SDGs) and executing the strategies toward ending preventable maternal
and neonatal mortality. However, the frequency of infection in pregnancy is poorly under-
stood; a review of maternal morbidity identified no published systematic literature review of
infection incidence, making it the one major direct cause of maternal morbidity without such
a review to our knowledge [5]. A commonly cited estimate of 4% for puerperal sepsis, mod-
elled for the 2000 Global Burden of Disease (GBD), is based on a single-centre United States
(US) study, two African studies comparing home and hospital, and a Cochrane review on anti-
biotic prophylaxis for cesarean section comprising 66 studies [6]. Recent 2017 GBD data esti-
mate 12.1 million incident cases of maternal sepsis and other maternal infections, including
mastitis [7].
A challenge in quantifying the incidence of pregnancy-related infection is the variety of
terms, definitions, time periods, sites, and severity of infections used, partly reflecting the
breadth of infectious disease in this period. A commonly used term such as puerperal sepsis
can range from localised symptoms and signs of genital tract infection [8] to more dissemi-
nated disease, including peritonitis, pyaemia, and sepsis [9], and with time periods that can
vary from 10 days [10] to 42 days postpartum [9] and sometimes include sepsis in labour [8].
In partial response to this quantification challenge, a new definition for maternal sepsis was
published in early 2018 [2]. However, the challenges remain in relation to less severe disease.
This review focusses on recent epidemiological evidence for the incidence of ‘maternal peri-
partum infection’, defined by the World Health Organization (WHO) in 2015 to encompass
infections of the genital tract and surrounding tissues from onset of labour or rupture of mem-
branes until 42 days postpartum [11]. At a time of increased global attention on maternal sep-
sis, this group of infections was chosen as being notable for causing over half the cases of
severe maternal sepsis in the UK. In addition, the direct association of maternal peripartum
infection with the process of giving birth presents key opportunities for prevention and for
protecting the efficacy of antibiotics, amidst growing concerns about antimicrobial resistance
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[11]. To aid prioritisation by decision makers and guide future research, we set out to estimate
the average global incidence of maternal peripartum infection.
Methods
The review was registered with PROSPERO [CRD42017074591] and conducted according to
PRISMA guidelines (S1 PRISMA Checklist).
Search strategy
We searched Medline, EMBASE, Global Health, Popline, CINAHL, the Latin American and
Caribbean Health Science Information (LILACS) database, Africa-Wide Information, and
regional WHO online databases using Global Index Medicus from January 2005 to June 2016.
Search strategies were customised to each electronic database’s individual subject headings
and searching structure (S1 Text). The approach was to include articles if their abstract, title,
or keywords contained a maternal term, an infection term, and a term for incidence/
prevalence.
Exclusion criteria
All identified studies were systematically assessed, irrespective of language or study design. For
clinical trials in which the infection risk differed between study arms (p< 0.05), we used the
control arm or the arm most similar to usual care. There were no case-control studies in which
incidence/prevalence could be estimated.
Studies were excluded if their titles or abstracts indicated they had any of the following:
• No data on maternal peripartum infection
• A composite outcome from which it was not possible to extract data on maternal peripartum
infection alone
• Only a subgroup of women at higher risk of infection than the general population of peripar-
tum women (e.g., only cesarean section deliveries or only women with diabetes)
• No quantitative data
• No numerator
• No denominator for the total population of women
• Fewer than 30 participants
• Data collected before 1990, because of potential decreases in incidence over time. If a study
spanned 1990 but disaggregated by year, data from 1990 onwards were used
• Conference and poster abstracts
• No primary data, except for reviews, which were hand-searched for additional primary
studies.
We sought the full text for all remaining studies, including those for which the abstract had
insufficient information to decide. The same exclusion criteria applied to full texts.
Outcome definitions
WHO defines maternal peripartum infection as ‘a bacterial infection of the genital tract or sur-
rounding tissues occurring at any time between the onset of rupture of membranes or labour
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and the 42nd day postpartum’ [11]. We considered this to encompass specific constituent
infections, namely chorioamnionitis in labour, puerperal endometritis, and wound infection
following cesarean section, perineal tear, or episiotomy. We included sepsis occurring within
the defined time period, restricted to sepsis of genital tract or wound origin when possible. We
included a fifth category, ‘maternal peripartum infection’, for studies with a composite out-
come of two or more of the above infection types or those that used a broader or unspecified
definition of infection within the peripartum period.
Measures of frequency
We aimed to estimate the incidence risk of infection in the peripartum period, defined as cases
of infection emerging until 42 days postpartum among women who were infection-free at the
start of labour. Because the starting point is clear (labour) and the follow-up period is short (42
days), we considered most studies to have approximated a measure of incidence risk (rather
than a rate or period prevalence) and report the results as such.
Screening and data extraction
We used the Institute of Education software, Eppi-Reviewer 4, to store citations and full-text
articles, to detect duplicates, and to code screening and data extraction. SLW and AM double-
screened 300 (approximately 1%) title and abstracts to ensure consistency; the rest were single-
screened. Full-text screening and extraction was conducted by SLW, AM, and MB, with
approximately 8% of articles double-screened and extracted to ensure consistency. AM
extracted Spanish papers, and MB extracted Portuguese papers. LP screened over 40 Chinese-
language papers and extracted from the included studies. Queries were resolved through dis-
cussion and, when necessary, with input from a third reviewer (OMRC). Nine authors were
contacted to clarify study eligibility.
Data extracted included language, location and dates of study, study population, study
design, sampling, outcome definition, denominator, time period for observing infection, data
source, diagnosis, and incidence of infection (S2 Text).
Critical appraisal of studies
We appraised the quality of each study outcome according to criteria in Table 1, adapted from
Joanna Briggs Institute criteria for assessing incidence/prevalence studies [12]. For each crite-
rion, estimates were classified as having met the criteria or not or of providing insufficient
information to judge. Estimates meeting all five criteria were considered high-quality.
Table 1. Quality assessment criteria.
Quality Assessment Criteria
1 Were study participants representative of the study target population?
(appropriate recruitment strategy and sampling)
Selection bias
2 Was data analysis conducted with sufficient coverage of the identified sample?
(refusals and loss are small [<15%] and unlikely to be related to the outcome)
Attrition/missing data
3 Was a clear, standard definition used for maternal infection? Measurement bias
4 Was infection measured reliably using trained/educated data collectors,
appropriate/reliable diagnostic procedures, or reliable forms of retrospective
data (clinical records meeting standard definitions)?
Measurement bias
5 Were study subjects and setting described in sufficient detail to determine
whether results are comparable with other studies?
Poor characterisation of study
population
https://doi.org/10.1371/journal.pmed.1002984.t001
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To determine whether a standard definition was used (criterion 3), we compared the study
definition to internationally recognised definitions for each infection (Table 2). The most
recent definition of sepsis (Sepsis-3) agreed upon in early 2016 [13] and the related definition
for maternal sepsis [2] proposed by WHO and JHPIEGO in 2017 were not used because these
supersede our included studies; however, these revised definitions are similar to the definition
for severe sepsis.
Table 2. Standard definitions for infection outcomes.
Subgroup Definition Additional Comments
Chorioamnionitis
[14]
Fever (>38˚C) plus one of Studies of histological chorioamnionitis and microbial
invasion of the amniotic fluid were excluded from the review.a) maternal tachycardia,
b) foetal tachycardia,
c) uterine tenderness, or
d) foul-smelling vaginal discharge during labour
Endometritis [15] At least two of the following:
a) fever (>38˚C),
b) abdominal pain with no other recognised cause,
c) uterine tenderness with no other recognised cause, or
d) purulent drainage from uterus
Wound infection [15] Superficial One of
a) purulent drainage,
b) organisms cultured,
c) incision deliberately opened AND at least one of pain,
tenderness, swelling, erythema, or heat, or
d) diagnosis by attending doctor
Deep Involves fascia and muscle and one of
a) purulent drainage,
b) spontaneous dehiscence or reopening AND organisms
identified AND symptoms similar to superficial infection, or
c) abscess
Organ/space Deeper than fascia and meets criterion for a specific organ/
space infection, e.g., endometritis, and one of
a) purulent drainage from a drain,
b) organisms, or
c) abscess
Sepsis [16] Infection plus
SIRS
At least two of We also accepted slightly different ranges (e.g., heart rate
>100/minute, WCC >17,000/mm3) because of uncertainty
regarding appropriate values for pregnant and postpartum
women.
a) temperature >38˚C or <36˚C,
b) heart rate >90/minute,
c) respiratory rate >20/minute or PaCO2 <32 mm Hg, and/
or
d) WCC >12,000/mm3 or <4,000/mm3 or >10% immature
bands
Severe sepsis Sepsis associated with organ dysfunction, hypoperfusion, or
hypotension. Abnormalities included, but were not limited
to, lactic acidosis, oliguria, or an acute alteration in mental
status
Studies that used management indicators of severe disease
such as ICU admission or prolonged hospital stay were also
accepted.
Blood stream
infection
Positive blood culture
Maternal peripartum
infection
Two or more of the above definitions, presented as a
composite outcome
Abbreviations: SIRS, systemic inflammatory response syndrome; WCC, white cell count.
https://doi.org/10.1371/journal.pmed.1002984.t002
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If all study cases fell within these definitions, the criterion was met, even if the study definition
was more restrictive and may have consequently underestimated infection incidence. Reference
to national guidelines or obstetric textbooks met the criteria, as did clearly specified and appropri-
ate ICD-9/10 codes (S1 Table). No codes exactly match the WHO definition of maternal peripar-
tum infection, but we classified studies using ICD-9 670 (major puerperal infection, including
endometritis and puerperal sepsis) [17] and ICD-10 O86 (other puerperal infection, including
endometritis and wound infection) [18] as having measured maternal peripartum infection.
Data management and analysis
We analysed infection incidence estimates separately for chorioamnionitis, endometritis,
wound infection, sepsis, and maternal peripartum infection.
We exported and managed data in Microsoft Excel and STATA 15.1. We extracted informa-
tion on study characteristics with potential to influence the risk of infection for use in metare-
gression. We categorised geographical location using SDG world regions [19]. We created a
variable named ‘study extent’ to reflect how nationally representative the study population might
be: national level (total population or representative sample), state/regional level, health facility
network (e.g., surveillance network or insurance scheme), two or more facilities or field sites,
and single facility or field site. Data collection was coded as routine or specific to the study. We
coded diagnostic method as clinical or based on reported symptoms, except for chorioamnioni-
tis, for which we compared the use of ICD codes with specified clinical signs. We grouped total
follow-up time as being until hospital discharge, 7 days, 30 days, or 42 days postpartum. We
grouped studies as only including low-risk women (e.g., low obstetric/medical risk, live birth,
vaginal delivery, singleton pregnancy, or term birth) versus including all women who delivered.
We conducted meta-analyses in R version 3.5.0 using the meta [20] and metafor packages
[21] to obtain a weighted pooled estimate of incidence of each infection outcome 1) for all
studies, 2) for high-quality studies, and 3) stratified by world region. The pooled estimate of
sepsis was also stratified by three levels of severity. When studies using nationally representa-
tive databases measured the same infection outcome over the same dates, we kept the study
with the longest time period.
Infection incidence risk (as a proportion) was transformed using the Freeman–Tukey
transformation to approximate a normal distribution and stabilise the variance [22, 23].
Because study designs and outcome definitions varied, we used random effects to combine
study estimates [12]. The tau2 measure of between-study heterogeneity was estimated using
restricted maximum likelihood [24]. The pooled estimates were backtransformed, and results
were presented as proportions. We generated prediction intervals to provide a predicted range
for the true incidence in any individual study [25]. As sensitivity analyses, we calculated stan-
dardised residuals, removed outliers with p> 0.05 (based on the t distribution), and noted
changes in heterogeneity and prediction intervals.
We used metaregression and reported odds ratios (ORs), 95% Confidence Intervals (CIs),
and p-values from Wald-type tests to explore whether world region or study characteristics
influenced infection incidence. Infection risk was log-transformed, and univariate random-
effects models were used to explore associations between each variable and odds of infection.
World region and variables with evidence of association (p< 0.1) were included in multivari-
able models unless data were sparse or closely correlated.
Results
Fig 1 shows the 31,528 potentially relevant articles identified, of which 1,543 were eligible for
full-text review after title and abstract screening. We could not find two full texts. Of the
Incidence of maternal peripartum infection
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Fig 1. Flow diagram of studies.
https://doi.org/10.1371/journal.pmed.1002984.g001
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remaining 1,541 full texts screened, 111 were included. Common reasons for exclusions were
ineligible types of publication (N = 493) or for which the study involved only a subgroup of
high-risk women (N = 405), e.g., cesarean deliveries only. Most included papers were in
English, with six in Chinese [26–31], four in Spanish [32–35], four in Portuguese [36–39],
three in French [40–42], and one each in Bulgarian [43], Bosnian [44], and Romanian [45].
Twenty-seven studies reported chorioamnionitis, 38 reported endometritis, 28 reported
wound infection, 27 reported sepsis, and 28 reported maternal peripartum infection (S2
Table–S6 Table).
Description of study populations
The 111 studies included data from 46 countries. Four studies were randomised controlled tri-
als [28, 46–48], two were before–after intervention studies [27, 49], and the remainder were
observational cohort or cross-sectional studies. Three studies had multiple countries: one cov-
ered nine European countries, a second involved nine Asian countries, and the third had sites
in South Asia, Latin America, and sub-Saharan Africa. Of the remaining studies, 57 occurred
in North America and Europe, of which 38 were in the US. There were 14 in Central and
South Asia, 12 in East and Southeast Asia, 11 in Latin America, seven in sub-Saharan Africa,
six in Western Asia and North Africa, and one in Australia. Nearly half the studies were con-
ducted in one hospital, but many studies also attempted to capture all births in a country or a
representative sample of them using birth certificate data or national hospital databases. In the
regions/countries using such hospital databases (North America, Europe, Japan, and Thai-
land), over 95% of all births are in hospital facilities. In low- and middle-income countries
(LMICs), only nine studies (in 10 countries: Tanzania, Nigeria, Egypt, Bangladesh, India, Paki-
stan, Argentina, Guatemala, Kenya, and Zambia) sought to capture population-level data.
Study quality
Quality scores for the studies are available in S7 Table. When studies had multiple infection
outcomes, the lowest score is presented. Of 111 studies, 19% met all five quality criteria, 37%
met four, 22% met three, 14% met two, 7% met one, and 2% did not meet any. Only 41% of
studies used a standard definition for infection, and 37% also measured infection reliably,
thereby meeting both measurement criteria. In 13% of studies, there was attrition or missing
data in >15% of observations, and 31% of studies had a risk of selection bias. Women or study
sites were poorly characterised in 25% of studies.
Incidence of infection
Incidence results are presented separately for the five infection outcomes (Table 3). Six studies
contributed no data to the meta-analyses because of overlapping populations and dates [50–
55]. Heterogeneity was high, as measured by I2 (>99% for all pooled estimates), but tau2 values
were small and are probably more meaningful for these data since they measure actual
between-study variance [56]. We identified six outlier estimates, all with high infection inci-
dence, described below. One single-facility US study of chorioamnionitis in low-risk pregnan-
cies provided no infection definition [57]. Three studies classified as endometritis from
Bangladesh, Pakistan, and Turkey relied on self-reported symptoms of pelvic or vaginal infec-
tion [58–60]. An Indian study gave no definition for their measure of self-reported puerperal
sepsis, collected up to six months after delivery [61], and similarly, a Nigerian study gave no
definition for their measure of self-reported postpartum infection collected up to three years
after giving birth [62]. Removal of these outliers did not change I2 but led to important
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reductions in both tau2 and prediction intervals; therefore, meta-analyses results are presented
after removing these outliers.
Chorioamnionitis
Chorioamnionitis incidence ranged from 0.6% to 19.7%, with a pooled incidence of 4.1% (95%
CI 2.5%–6.2%) (Table 3). The prediction interval was wide, suggesting the incidence in any
future study could lie between 0% and 18%. In North America and Europe, the pooled inci-
dence was 4.9% (Fig 2). Only three studies were conducted in other regions. In the univariate
metaregression (Table 4), study extent explained 38% of the heterogeneity, with the highest
incidence seen in single-hospital studies. Studies including only singleton deliveries or only
term pregnancies also had higher incidence, but almost all of these studies were conducted at
single facilities.
Seven high-quality studies (meeting all five quality criteria) had a pooled infection inci-
dence of 3.9%. The lowest incidence (0.9%) was reported in low-risk women delivering at a
hospital in Bangkok, Thailand [63]. The other six estimates were from the US. Two used the
US National Inpatient Sample (NIS) database and recorded a chorioamnionitis ICD-9 code in
1.7% of women in 1998–2008 [64] and 2.6% in 2008–2010 [65]. Two studies from Kaiser Per-
manente Medical Program (KPMP) hospitals in California also used ICD-9 codes and
recorded 3.5% of women in 1995–1999 [66] and 4.0% in 2010 [67]. The highest incidences
were reported in studies at single tertiary hospitals: 6.1% in Chicago [68] and 12.6% in Califor-
nia (among women delivering a live, single, term baby) [69].
Endometritis. Endometritis incidence ranged from 0%–16.2% with a pooled incidence of
1.4% (95% CI 0.9%–1.9%) (Table 3). The prediction interval suggests a true incidence of up to
6% in future studies. Pooled incidence was similar across most world regions, ranging from
1.3%–1.9%. However, it was much lower in studies from Eastern Asia and Southeastern Asia
at 0.3% (Fig 3). In univariate metaregression, no variables were associated with incidence
(Table 5).
Six high-quality studies had a pooled incidence of 1.6%. The lowest incidence (0.3%) was in
women delivering vaginally at 66 hospitals in a surveillance network in France [70] with fol-
low-up to 30 days postpartum. The other five studies only reported infections until hospital
discharge after childbirth. Endometritis ICD-9 codes were recorded for 1.4% of women in the
NIS database [65] and 1.2% of low-risk deliveries at Kaiser Permanente hospitals in California
[66]. Higher infection incidence (2.4%–2.5%) was reported in three single-centre studies: two
in the US [69, 71] and one in Argentina [32].
Wound infection. Wound infection incidence ranged from 0%–10.9%, with a pooled
incidence of 2.1% (95% CI 1.2%–3.2%) (Table 3). The prediction intervals suggest the
Table 3. Summary estimates for all infection outcomes.
All Studies Meta-Analyses of All Studies (Excluding
Outliers)
High-Quality
Studies
Meta-Analysis of High-Quality Studies
Infection Type N Range % N Pooled Incidence % (95% CI) 95% PI N Range % N Pooled Incidence % (95% CI) 95% PI
Chorioamnionitis 28 0.6–19.7 21 4.1 (2.5–6.2) 0–18.0 8 0.9–12.6 7 3.9 (1.8–6.8) 0–17.9
Endometritis 41 0–16.2 36 1.4 (0.9–1.9) 0–5.9 6 0.3–2.5 6 1.6 (0.9–2.5) 0–6.0
Wound infection 30 0–10.9 30 2.1 (1.2–3.2) 0–11.2 1 1.2 1 1.2 (1.0–1.5) –
Sepsis 31 0–3.8 26 0.11 (0.04–0.21) 0–0.6 13 0.02–0.13 11 0.05 (0.03–0.07) 0–0.18
Maternal peripartum infection 30 0.1–18.1 26 1.9 (1.3–2.8) 0–7.9 7 0.2–5.8 7 1.1 (0.3–2.4) 0–8.3
Abbreviations: CI, Confidence Interval; PI, Prediction Interval.
https://doi.org/10.1371/journal.pmed.1002984.t003
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incidence could be as high as 11.2% in future studies. Pooled incidence was highest in Eastern
Asia and Southeastern Asia (6.2%) and lowest in the US and Europe (0.9%) (Fig 4). In univari-
ate metaregression, single-site studies were associated with higher infection incidence. Unex-
pectedly, six studies that only included vaginal deliveries had higher pooled incidence than
studies that included all delivery methods. A substantial proportion (44%) of between-study
heterogeneity was explained by world region and study extent in multivariable metaregression
(Table 6).
Only one study met all five quality criteria and identified 1.2% of women with cesarean or
episiotomy wound infection from medical records at a single Brazilian hospital [39].
Sepsis. Incidence of sepsis—combining systemic inflammatory response syndrome
(SIRS), severe sepsis, and blood stream infection—ranged from 0%–3.8%, with pooled
Fig 2. Forest plot of chorioamnionitis incidence by world region. CI, Confidence Interval.
https://doi.org/10.1371/journal.pmed.1002984.g002
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incidence 0.10% (95% CI 0.04%–0.21%) (Table 3). The prediction interval suggests the inci-
dence could be up to 0.6% in future studies. Pooled incidence was 0.11% for SIRS, 0.08% for
severe sepsis, and 0.10% for blood stream infection (S1 Fig). The majority of estimates came
from the US and Europe, with a pooled incidence of 0.10%. Latin America had a similar inci-
dence of 0.08%, whilst Central and South Asia had slightly more infection (0.27%) (Fig 5). In
univariate analysis, there was weak evidence for an association with world region, no evidence
for an association with severity, but increased incidence of sepsis with longer follow-up.
Women with singleton pregnancies had higher infection incidence, but the two studies
involved also had longer follow-up periods. Data were too sparse to investigate other factors or
conduct multivariable metaregression (Table 7).
Eleven high-quality estimates produced a pooled incidence of 0.05%. Four high-quality esti-
mates of SIRS used data from the delivery admission: NIS (0.03%) [72], all Californian hospi-
tals (0.10%) [73], all hospitals in Thailand (0.13%) [74], and one reference hospital in São
Paolo, Brazil (0.04%) [37]. Incidence of severe sepsis with organ dysfunction was low: NIS
(0.01%) [72], Californian hospitals (0.05%) [73], and no cases in a near-miss study at one hos-
pital in Gabon [41]. US data from NIS and the National Hospital Discharge Survey (NHDS)
estimated blood stream infection at 0.02% [65] and 0.07% [75]. One region in Denmark and
two hospitals in Ireland followed women until 30 and 42 days postpartum and identified blood
stream infection in 0.06% [76] and 0.11% [77], respectively.
Table 4. Chorioamnionitis univariate metaregression.
Factor No. of Studies OR 95% CI p-Value R2 (%)
Region North America and Europe 18 1
Central Asia and South Asia 1 0.17 0.02–1.26
East Asia and Southeast Asia 2 0.22 0.05–0.87 0.03 23.7
Study extent Single site 12 1
2+ sites 2 0.11 0.02–0.54
Network 2 0.32 0.09–1.14
State 1 0.29 0.05–1.58
National 4 0.28 0.11–0.74 0.007 37.6
Number of foetuses All pregnancies 8 1
Singleton only 13 2.64 1.07–6.53 0.04 13.9
Delivery mode All deliveries 18 1
Vaginal only 3 1.41 0.37–5.43 0.61 0
Gestational age All gestations 12 1
Term only 9 3.36 1.56–7.24 0.002 35.3
Live birth All deliveries 12 1
Live birth only 9 1.16 0.44–3.04 0.77 0
Low risk All women 16 1
Low-risk pregnancy only 5 1.56 0.52–4.69 0.43 0
Diagnosis ICD9/10 6 1
Fever and other signs 7 0.85 0.25–2.95
Fever only 8 1.47 0.46–4.74 0.63 0
Data collection Routine 14 1
Study 5 1.62 0.51–5.19
Unclear 2 1.29 0.25–6.52 0.71 0
Abbreviations: CI, Confidence Interval; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1002984.t004
Incidence of maternal peripartum infection
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002984 December 10, 2019 12 / 27
Fig 3. Forest plot of endometritis incidence by world region. CI, Confidence Interval.
https://doi.org/10.1371/journal.pmed.1002984.g003
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Maternal peripartum infection. Incidence of maternal peripartum infection ranged from
0.1%–18.1%, with pooled incidence of 1.9% (95% CI 1.3%–2.8%) (Table 3). The prediction
intervals suggest the incidence could be up to 8% in future studies. Pooled incidence in the US
and Europe was 1.9%, and in East Asia, it was 2.6%. Other regions contained only one or two
studies (Fig 6), and there was no evidence that world region was associated with incidence. In
univariate analysis, study extent was strongly associated with incidence. Studies with only low-
risk pregnancies or vaginal deliveries also showed some evidence of association, although this
was lost after adjusting for study extent (Table 8); many of these studies used either broad or
poorly described definitions of infection.
Pooled incidence in seven high-quality studies was 1.1%. The highest incidence of 5.8% was
from a single-facility study in China, using Ministry of Health standard diagnosis of genital
tract and cesarean section incision infection [30]. All the other estimates extracted ICD-9 or 10
codes for major/other puerperal infection from state or nationally representative hospital data-
bases with incidences of 0.2% in Canada and Thailand [74, 78], 0.5% using NIS data [79], 0.8%
in all National Health Service (NHS) hospital deliveries in the UK with follow-up to 42 days
Table 5. Endometritis metaregression.
Factor No. of Studies OR 95% CI p-Value R2 (%)
Region North America and Europe 14 1
Central Asia and South Asia 3 1.09 0.35–3.46
East Asia and Southeast Asia 4 0.18 0.06–0.59
Latin America & Caribbean 8 0.91 0.39–2.11
Sub-Saharan Africa 4 0.99 0.33–2.97
West Asia and North Africa 2 1.03 0.25–4.29 0.12 8.0
Study extent Single site 25 1
2+ sites 4 1.82 0.66–4.99
Network 2 0.48 0.13–1.81
State 2 1.44 0.38–5.51
National 2 0.34 0.09–1.29 0.20 6.9
Number of foetuses All pregnancies 23 1
Singleton only 12 1.52 0.75–3.07 0.24 2.6
Delivery mode All deliveries 31 1
Vaginal only 4 0.60 0.19–1.93 0.39 0
Gestational age All gestations 27 1
Term only 8 1.17 0.52–2.64 0.70 0
Live birth All deliveries 30 1
Live birth only 5 1.41 0.55–3.63 0.47 0
Low risk All women 28 1
Low-risk pregnancy only 7 0.72 0.28–1.84 0.49 0
Diagnosis Clinical 30 1
Self-report 5 1.58 0.62–4.02 0.34 0
Data collection Routine 25 1
Study 10 1.25 0.58–2.68 0.57 0
Follow-up� Hospital discharge 20 1
7 days 5 1.13 0.39–3.25
8–42 days 9 0.87 0.38–1.96 0.90 0
�Length of follow-up was missing for one study. Abbreviations: CI, Confidence Interval; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1002984.t005
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Fig 4. Forest plot of wound infection incidence by world region. CI, Confidence Interval.
https://doi.org/10.1371/journal.pmed.1002984.g004
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[80], and 0.9% using birth certificate data in California [81]. One large US study also included
chorioamnionitis and reported 2.0% of women with infection [82].
Discussion
We systematically reviewed the incidence of maternal peripartum infection and identified 111
studies from 46 countries, representing all world regions, from among 31,528 potential studies.
Pooled infection incidence in high-quality studies was 3.9% (95% CI 1.8%–6.8%) for chor-
ioamnionitis, 1.6% (95% CI 0.9%–2.5%) for endometritis, 1.2% (95% CI 1.0%–1.5%) for
wound infection (one study), and 1.1% (95% CI 0.3%–2.4%) for maternal peripartum infec-
tion. Pooled incidence of sepsis was 0.05% (95% CI 0.03%–0.07%). Studies of composite out-
comes had, on average, a lower incidence than obtained by summing other infection outcomes
(1.1% versus 6.7%), probably because they rarely included chorioamnionitis (3.9%) but also
because coinfections can occur.
Comparing our results to other global estimates is complicated by the different definitions
used. The recent 2017 GBD global incidence of maternal infection of 12.1 million women [83]
Table 6. Wound metaregression.
Factor No. of Studies OR 95% CI p-Value R2 (%) Adj. OR 95% CI
R2 = 43.78%
Region North America and Europe 11 1 0.02 25.2 1
Central Asia and South Asia 7 3 0.83–10.82 1.84 0.48–7.12
East Asia and Southeast Asia 4 9.1 2.11–39.20 3.85 0.89–16.72
Latin America and the Caribbean 3 4.85 0.96–24.52 2.06 0.42–10.06
Sub-Saharan Africa 3 5.98 1.03–34.69 2.75 0.50–15.22
Western Asia and Northern Africa 1 0.52 0.22 0.02–2.37
Study extent Single site 22 1 0.002 37.9
2+ sites 2 0.11 0.02–0.80 0.13 0.02–0.94
State 4 0.13 0.04–0.46 0.24 0.05–1.04
National 1 0.13 0.01–1.30 0.23 0.02–2.44
Number of foetuses All pregnancies 21 1
Singleton only 8 1.95 0.56–6.75 0.29 3.5
Delivery mode All deliveries 24 1
Vaginal only 5 4.64 1.21–17.76 0.02 17.8
Gestational age All gestations 24 1
Term only 5 0.85 0.18–4.08 0.84 0
Live birth All deliveries 26 1
Live birth only 3 1.31 0.22–7.76 0.76 0
Low risk All women 21 1
Low-risk pregnancy only 8 0.60 0.17–2.14 0.43 0
Diagnosis Clinical 25 1
Self-report 4 1.58 0.62–4.02 0.33 0
Data collection Routine 16 1
Study 8 2.99 0.87–10.25
Unclear 5 1.92 0.40–9.19 0.21 5.9
Follow-up� Discharge 17 1
Day 7 2 3.57 0.42–30.25
8–42 days 8 1.26 0.38–4.22 0.50 0
�Length of follow-up was missing from two studies. Abbreviations: Adj., adjusted; CI, Confidence Interval; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1002984.t006
Incidence of maternal peripartum infection
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002984 December 10, 2019 16 / 27
Fig 5. Forest plot of sepsis incidence by world region. CI, Confidence Interval.
https://doi.org/10.1371/journal.pmed.1002984.g005
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translates to an estimated 8.2% of live births [84] but includes mastitis, so it is not compara-
ble with ours. Dolea and Stein’s older figure of 4% for puerperal sepsis [6] excludes surgical
site infection (SSI) but includes urinary tract infection. Our average estimates of endometri-
tis, maternal peripartum infection, and sepsis are all substantially lower, which may reflect
our exclusion of urinary tract infection or a reduction in infection since 2000. Our identifi-
cation of source estimates is vastly more comprehensive than either GBD or Dolea and
Stein, and we do not rely on modelling. A recently published review of infection following
cesarean section in sub-Saharan Africa reports an SSI rate of 15.6% that, at their reported
cesarean section rate of 12.4%, corresponds to 1.9% for the total population of women giv-
ing birth [85]. This is a little lower than the average incidence (3.4%) in our three fairly
small, poor-quality African studies but does not include perineal wound infection and does
lie within our prediction interval.
Table 7. Sepsis metaregression.
Factor No. of Studies OR 95% CI p-Value R2 (%)
Severity SIRS� 13 1
Severe sepsis 5 0.32 0.08–1.35
Septicaemia/peritonitis 7 0.52 0.15–1.78 0.25 2.6
Region North America and Europe 16 1
Central Asia and South Asia 3 11.00 2.25–53.75
East Asia and Southeast Asia 1 1.23 0.12–12.50
Latin America and the Caribbean 3 0.83 0.18–3.84
Sub-Saharan Africa 1 0.13 0.004–4.79
West Asia and North Africa 1 0.96 0.09–10.15 0.06 25.1
Study extent Single site 8 1
2+ sites 2 6.84 0.83–56.64
Network 2 2.06 0.25–17.12
State 6 0.92 0.21–4.08
National 7 0.83 0.20–3.50 0.32 2.5
Number of foetuses All deliveries 23 1
Singleton only 2 6.64 1.11–39.63 0.04 13.5
Delivery mode All deliveries 23 1
Vaginal only 2 1.24 0.08–19.58 0.88 0
Gestational age All gestations 25 –
Term only 0
Live birth All deliveries 24 1
Live birth only 1 0.37 0.02–5.54 0.47 0
Low risk All women 24 1
Low-risk pregnancy only 1 0.42 0.01–14.91 0.64 0
Diagnosis Clinical 25
Self-report 0
Data collection Routine 24 1
Study 1 2.99 0.87–10.25
Unclear 1 1.92 0.40–9.19 0.21 5.9
Follow-up� Discharge/day 7 13 1
Day 8–42 10 3.57 1.55–8.22 0.003 27.2
�Length of follow-up was missing for two studies. Abbreviations: CI, Confidence Interval; OR, odds ratio; SIRS, systemic inflammatory response syndrome.
https://doi.org/10.1371/journal.pmed.1002984.t007
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Fig 6. Forest plot of maternal peripartum infection incidence by world region. CI, Confidence Interval; LMICs, low- and middle-income
countries.
https://doi.org/10.1371/journal.pmed.1002984.g006
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Limitations of included studies
The quality of many studies was poor, with potential for bias. Measurement bias was possible
in 63% of studies, primarily because the infection was not defined, or the definition used was
too broad and risked overestimating incidence. This explains part of the between-study hetero-
geneity observed. Attrition was minimal because most studies were cross-sectional or had
short follow-up periods. There was potential selection bias in nearly one-third of studies: most
trials did not describe initial selection methods, and pair-matched studies produced nonran-
dom control groups; however, it is unclear whether and how this might have affected infection
incidence. Restricting the results to high-quality studies made little difference to the pooled
estimates for chorioamnionitis or endometritis but produced lower pooled incidence for the
other outcomes, although with similar prediction intervals. This lower incidence may be an
underestimate of infection because some high-quality studies had narrower outcome defini-
tions than the standards. In addition, only one lower-middle–income and four upper-middle–
income countries contributed to high-quality estimates, reducing their generalisability to
LMICs.
Table 8. Maternal peripartum infection metaregression.
Factor No. of Studies OR 95% CI p-Value R2 (%) Adj. OR 95% CI
R2 = 35.7%
Region North America and Europe 12 1
Central Asia and South Asia 1 2.63 0.24–28.80
East Asia and Southeast Asia 7 1.37 0.45–4.16
Australia and New Zealand 2 0.82 0.15–4.61
Latin America and the Caribbean 1 1.64 0.16–17.05
West Asia and North Africa 2 0.76 0.13–4.38 0.93 0
Study extent Single site 9 1 1
2+ sites 5 1.22 0.47–3.17 1.32 0.50–3.48
Network 1 2.20 0.38–12.80 1.54 0.24–9.87
State 3 0.72 0.23–2.24 0.88 0.27–2.85
National 7 0.26 0.10–0.61 0.005 35.6 0.29 0.12–0.70
Number of foetuses All deliveries 14 1
Singleton only 11 1.66 0.71–3.87 0.24 0.7
Delivery mode All deliveries 22 1
Vaginal only 3 3.83 1.16–12.67 0.03 14.3
Gestational age All gestations 17 1
Term only 8 0.89 0.36–2.23 0.81 0
Live birth All deliveries 20 1
Liver birth only 5 1.61 0.57–4.59 0.37 0
Low risk All women 19 1 1
Low-risk pregnancy only 6 2.34 0.90–6.04 0.08 7.3 1.74 0.71–4.27
Diagnosis Clinical 24 –
Unclear 1
Data collection Routine 18 1
Study 3 2.67 0.71–10.10
Unclear 4 0.74 0.22–2.52 0.28 1.5
Follow-up Discharge 20 1
Until day 42 5 1.17 0.40–3.41 0.77 0
Abbreviations: Adj., adjusted; CI, Confidence Interval; OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1002984.t008
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We explored and quantified the importance of world region and study characteristics on
infection risk using metaregression to explain heterogeneity and better compare study esti-
mates. Unfortunately, our analyses were limited by data sparsity. Beyond North America and
Europe, data were scarce, especially from sub-Saharan Africa and Western Asia and North
Africa. We found some evidence for increased wound infection outside North America and
Europe but saw a mixed picture for endometritis, with surprisingly low incidence in East and
Southeast Asia. In common with other studies, we found a higher incidence of SSI in LMICs,
which could reflect differences in surgical and infection control practices [86]. However, stud-
ies outside North America and Europe were also more likely to be at single facilities, use self-
reported symptoms, and collect data specifically for the study—all features that relate to higher
incidence.
For chorioamnionitis, wound infection, and maternal peripartum infection, there was evi-
dence that study extent was associated with infection risk. Pooled incidence was up to five
times higher in single-facility studies compared to estimates using nationally representative
databases, although the association was less clear with state-level studies. Large databases rely-
ing on routine medical records risk underestimating incidence because of missing or misclas-
sified data. Conversely, studies at single tertiary-level hospitals may represent higher risk
populations, especially in LMICs with low facility delivery rates, producing overestimates of
population-level incidence. We excluded studies of high-risk women from this review but
chose to retain single-facility studies and regress the effect of study extent on infection because
omitting single facilities would lead to extensive loss of data, especially from LMICs.
Longer follow-up (risk) period was unsurprisingly associated with higher sepsis incidence,
and a similar trend was observed with wound infection but lacked statistical evidence. This
supports the findings of one included study in which the majority of infections occurred after
hospital discharge [87]. Unfortunately, the majority of studies only collected data during hos-
pital admission and may therefore have missed many cases.
Expected low-risk groups, including live, term, singleton, and vaginal births, did not have a
lower infection risk compared to studies of all deliveries. This was surprising, but because the
majority of deliveries, even in population-level studies, are also low-risk, it is difficult to show
evidence of a difference. Occasionally, there was evidence of higher infection incidence in the
studies of low-risk groups, but numbers were often small, and results were confounded by
other study design factors.
Strengths and limitations of review
This review’s strengths include the very extensive search conducted and the inclusion of arti-
cles in all languages identified. However, studies published after June 2016 have not contrib-
uted to the findings. Our review adopted the 2015 WHO definition of maternal peripartum
infections and used international standard definitions among its quality criteria. It could be
criticised for not restricting included studies to those meeting the full WHO definition, includ-
ing the specified time period from onset of labour until 42 days postpartum. However, it is tell-
ing that none of the studies measured this exact outcome, and very few of those investigating
postpartum infection continued until 42 days.
The review reported infection outcomes as an incident risk. This assumes all women were
at risk (i.e., free of the infections under consideration) at the start of follow-up: onset of labour
or immediately postpartum. However, some studies were unable or did not seek to exclude
women with existing infections, potentially overestimating the incidence. Some studies only
assessed or interviewed women at one time point after delivery; however, follow-up periods
were short, so the chance of missing infections is small. We excluded studies that only assessed
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high-risk subgroups of women; however, we did not limit our review to population-level stud-
ies, potentially overestimating infection incidence, as discussed above. Conversely, we did
include groups of low-risk women, and so our pooled estimates may be an underestimate.
There are arguments against pooling estimates in the presence of extensive heterogeneity.
Although I2 was very high, this is driven by the substantial number of large, precise studies
[56]. Tau2 is a more relevant measure of heterogeneity in this case, and values were small.
Moreover, we believe that within our outcome groups, each study was attempting to measure
the same outcome, and therefore, the average estimates remain useful, although they should be
treated cautiously and not overinterpreted as measures of global incidence.
Conclusion
To our knowledge, this is the first global systematic review of maternal peripartum infection
incidence. It demonstrates that infection is an important complication of childbirth. More-
over, we found that a large proportion of these infections occurred in labour, with implications
for the baby and the mother. Postpartum infection incidence appears lower than modelled
global estimates, although the difference in definition limits comparability, and the proportion
of women affected is still considerable. At a time of growing concern about antimicrobial resis-
tance, these findings highlight the importance for clinicians and policymakers to focus efforts
on improved infection prevention practices to reduce this preventable cause of maternal mor-
bidity. Our study provides useful estimates to guide sample-size calculations for future inter-
vention research. However, we also highlight the paucity of data from LMICs and the
heterogeneity in study designs, quality, and infection definitions. Better-quality research, using
standard definitions and follow-up after hospital discharge, is required to improve comparabil-
ity between different study settings and to demonstrate the influence of risk factors and protec-
tive interventions.
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